Ligand profile
PDQ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4030 — DNA topoisomerase IV, B subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
PDQ- PDB
3ltn- UniProt (similar protein)
Q59961- Target protein
- VK055_4030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.3
- −1 ≤ LogP ≤ 5 0.83
- MW ≤ 500 Da 361.4
- LogP ≤ 5 0.83
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 99.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c2c(cc(c1N3CC[C@H](C3)[C@H](C)N)F)C(=O)N(C(=O)N2C4CC4)NCc1c2c(cc(c1N3CC[C@H](C3)[C@H](C)N)F)C(=O)N(C(=O)N2C4CC4)N
InChI=1S/C18H24FN5O2/c1-9-15-13(17(25)24(21)18(26)23(15)12-3-4-12)7-14(19)16(9)22-6-5-11(8-22)10(2)20/h7,10-12H,3-6,8,20-21H2,1-2H3/t10-,11+/m0/s1InChI=1S/C18H24FN5O2/c1-9-15-13(17(25)24(21)18(26)23(15)12-3-4-12)7-14(19)16(9)22-6-5-11(8-22)10(2)20/h7,10-12H,3-6,8,20-21H2,1-2H3/t10-,11+/m0/s1
SMONLCFJGCJROJ-WDEREUQCSA-NSMONLCFJGCJROJ-WDEREUQCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00521' 'PF01751
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PDQ →
- PDB RCSB structure 3ltn →
- UniProt UniProt Q59961 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PDQ”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4030.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 18
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).